Clinical Trials Logo

Colon Cancer clinical trials

View clinical trials related to Colon Cancer.

Filter by:

NCT ID: NCT01786200 Not yet recruiting - Colon Cancer Clinical Trials

Physiological Effects of Altering Cancer-related Inflammation

Start date: February 2013
Phase: N/A
Study type: Interventional

This prospective pilot study will examine whether the previously reported effects of NSAIDs on colorectal cancer may be modulated through alterations in tissue gene expression, up regulation of local immune cell infiltrates or down-regulation of the systemic inflammatory response.

NCT ID: NCT01775254 Completed - Colon Cancer Clinical Trials

The Inland Northwest Colon Cancer Survivor's Study

Start date: January 2013
Phase:
Study type: Observational

The overall purpose of this study was to address the following questions by describing the trajectory of early survivorship in individuals who undergo both surgical and medical management of colon cancer. What are the changes in quality of life, demands of illness, sexual function, and peripheral neuropathy, following curative resection during the first year of treatment and recovery? Is there an interaction between exposures to chemotherapy and changes over time in these outcomes?

NCT ID: NCT01772407 Completed - Colon Cancer Clinical Trials

Laparoscopic Surgery Equivalent to Open Surgery in Right Colon Cancer Surgery?

CHIRCOL
Start date: September 2009
Phase: N/A
Study type: Observational

The primary goal of this study is to compare in the long-term costs of laparoscopic or open right colectomy in patients sustaining a colon cancer controling for the carcinologic equivalence of the two surgical strategies. The secondary goals to compare long-term mortality, morbidity as well as quality of life of the two groups.The present study is an prospective multicentric observational trial taking into account the usual surgical strategy of every centers

NCT ID: NCT01744509 Recruiting - Colon Cancer Clinical Trials

PillCam Colon Capsule 2® (PCC2) in the Setting of Colorectal Cancer Screening Program

Start date: March 2011
Phase: N/A
Study type: Interventional

In this study the investigators evaluate the sensitivity of PCC2 (PillCam Colon Capsule 2 (R)) in identifying significant polyps in a CRC (Colo Recatal Cancer) screening program (primary outcome measure). Each enrolled patient underwent three procedures: colon capsule endoscopy, CT-colonography and optical colonoscopy. In this study the reference standard is represented by the segmental unblinded colonoscopy (the unblinding is based on results of both capsule endoscopy and Ct colonography) The investigators also evaluated the tolerability of PCC2 as compared to optical colonoscopy (OC) and CT-colonography (CTC).

NCT ID: NCT01744340 Completed - Clinical trials for Head and Neck Cancer

A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer

Start date: May 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if the full dose of eribulin mesylate can be safely given with the full dose of cetuximab. The activity of the combination of eribulin mesylate and cetuximab on recurrent head and neck cancer and colon cancer will also be assessed.

NCT ID: NCT01729416 Completed - Colon Cancer Clinical Trials

Prospective Randomized Controlled Trial Comparing Water and Air Colonoscopy in a Community Based Setting

Start date: February 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if screening colonoscopy performed on adults with the water exchange method, as opposed to the air method, will have a higher adenoma detection rate.

NCT ID: NCT01727388 Completed - Colon Cancer Clinical Trials

Informativeness to Digital Rectal Examination

RIFIONA
Start date: November 2012
Phase: Phase 3
Study type: Interventional

Digital rectal examination is an act clinically performed daily by physicians and surgeons. It remains the key diagnostic test and directs the therapeutic management of cancer of the lower and middle rectum. It can be done in two main positions: lateral decubitus, and supine. However, no randomized study in colorectal surgery is not interested in evaluating the best position to perform a full rectal exam.

NCT ID: NCT01724775 Recruiting - Surgery Clinical Trials

Efficacy and Safety Study of Complete Mesocolic Excision for Colon Cancer

ESCME
Start date: November 2012
Phase: N/A
Study type: Observational

In 2009, Prof. Hohenberger proposed complete mesocolic excision (CME) as standardized, in which the same principle of TME in rectal cancer has been applied to the colon. More and more surgeons pay attention to the rationality of this surgical approach. However, the clinical application researches are still few, in particular the prospective controlled study is still none. This clinical trial will compare the CME group and non-CME group to evaluate the outcome and safety of CME for apply in clinic.

NCT ID: NCT01714466 Completed - Colon Cancer Clinical Trials

Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening Colonoscopy

Start date: October 2012
Phase: Phase 2
Study type: Interventional

A study to assess the pharmacodynamics, safety and tolerability of a PEG-based bowel cleansing solution (MOVIPREP®)

NCT ID: NCT01692951 Recruiting - Breast Cancer Clinical Trials

Free Fatty Acid Metabolite Biomarkers for Cancer

Start date: August 2012
Phase: N/A
Study type: Observational

Surgical removal of tumor at an early stage remains the primary treatment for most cancers. However, there is currently no reliable screening blood test for detection of lung, colon, or breast cancer. The Specific Aims are to: 1) assess the diagnostic accuracy of six FFA metabolites to detect lung and colon cancer in surgical patients; 2)determine the rate and extent to which FFA metabolites decrease over time after surgery for lung and colon cancer; and, 3)determine the positive and negative predictive values and overall test accuracy for diagnostic prostate and breast biopsies.